Exact Mass: 483.2960886
Exact Mass Matches: 483.2960886
Found 292 metabolites which its exact mass value is equals to given mass value 483.2960886
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Taurolithocholate
Lithocholyltaurine is a bile salt formed in the liver from lithocholic acid conjugation with taurine, usually as the sodium salt. It solubilizes fats for absorption and is itself absorbed. Lithocholic acid, a hydrophobic secondary bile acid, is well known to cause intrahepatic cholestasis. There have been extensive studies on the mechanisms of lithocholate-induced cholestasis in animals. Lithocholate diminishes both the bile acid-dependent and independent bile flow. In humans, elevated levels of lithocholic acid are found in patients with chronic cholestatic liver disease. Lithocholyltaurine impairs both the bile canalicular contractions and the canalicular bile secretion, possibly by acting directly on the canalicular membranes in lithocholyltaurine-induced cholestasis. Lithocholyltaurine induce acute cholestasis-associated with retrieval of the bile salt export pump. The bile salt export pump (BSEP) of hepatocyte secretes conjugated bile salts across the canalicular membrane in an ATP-dependent manner. Hepatic retention of bile acids may lead to liver injury by hepatocyte apoptosis and eventually deterioration of cholestatic liver diseases. One mechanism of induced apoptosis by lithocholyltaurine is the induction of transcriptional activity of AP-1 (activation protein-1). (PMID: 16981261, 15763547, 16332456, 18164257) [HMDB] Lithocholyltaurine is a bile salt formed in the liver from lithocholic acid conjugation with taurine, usually as the sodium salt. It solubilizes fats for absorption and is itself absorbed. Lithocholic acid, a hydrophobic secondary bile acid, is well known to cause intrahepatic cholestasis. There have been extensive studies on the mechanisms of lithocholate-induced cholestasis in animals. Lithocholate diminishes both the bile acid-dependent and independent bile flow. In humans, elevated levels of lithocholic acid are found in patients with chronic cholestatic liver disease. Lithocholyltaurine impairs both the bile canalicular contractions and the canalicular bile secretion, possibly by acting directly on the canalicular membranes in lithocholyltaurine-induced cholestasis. Lithocholyltaurine induce acute cholestasis-associated with retrieval of the bile salt export pump. The bile salt export pump (BSEP) of hepatocyte secretes conjugated bile salts across the canalicular membrane in an ATP-dependent manner. Hepatic retention of bile acids may lead to liver injury by hepatocyte apoptosis and eventually deterioration of cholestatic liver diseases. One mechanism of induced apoptosis by lithocholyltaurine is the induction of transcriptional activity of AP-1 (activation protein-1). (PMID: 16981261, 15763547, 16332456, 18164257). D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents CONFIDENCE standard compound; INTERNAL_ID 61
Kanamycin B
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic KEIO_ID B028 Bekanamycin (Kanamycin B) is an aminoglycoside antibiotic produced by Streptomyces kanamyceticus, against an array of Gram-positive and Gram-negative bacterial strain[1][2].
Hydroxybuprenorphine
C29H41NO5 (483.29845760000006)
Hydroxybuprenorphine is a metabolite of Buprenorphine. Buprenorphine is a semi-synthetic opioid that is used to treat opioid addiction in higher dosages (>2 mg), to control moderate acute pain in non-opioid-tolerant individuals in lower dosages (~200 µg), and to control moderate chronic pain in dosages ranging from 20–70 µg/hour. It is available in a variety of formulations: Subutex, Suboxone (buprenorphine HCl and naloxone HCl; typically used for opioid addiction), Temgesic (sublingual tablets for moderate to severe pain), Buprenex (solutions for injection often used for acute pain in primary-care settings), Norspan and Butrans (transdermal preparations used for chronic pain). (Wikipedia)
Aminodeoxykanamycin
(17RS)-8-deoxo-17-(beta-D-glucopyranosyloxy)antidesmone
C25H41NO8 (483.28320260000004)
1beta-hydroxy-tirucalla-3,23-dione-7,24-diene-1(2->3)abeo-1-carboxamide|aphanamgrandin F
C30H45NO4 (483.33484100000004)
Thr Val His Lys
Taurolithocholic acid
C26H45NO5S (483.30182800000006)
D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents The bile acid taurine conjugate of lithocholic acid. KEIO_ID T072
Tauro 3a-OH-5b-cholanic acid
C26H45NO5S (483.30182800000006)
BA-134-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-134-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-134-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-134-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.
2-((4R)-4-((5S,9S,10S,12R,13R,14S,17R)-12-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
C26H45NO5S (483.30182800000006)
2-((4R)-4-((3R,5R,9S,10S,13R,14S,17R)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
C26H45NO5S (483.30182800000006)
2-((4R)-4-((5S,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
C26H45NO5S (483.30182800000006)
Lithocholyltaurine
C26H45NO5S (483.30182800000006)
D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids D013501 - Surface-Active Agents > D003902 - Detergents
Ala His Arg Thr
C19H33N9O6 (483.25536780000004)
Ala His Thr Arg
C19H33N9O6 (483.25536780000004)
Ala Arg His Thr
C19H33N9O6 (483.25536780000004)
Ala Arg Thr His
C19H33N9O6 (483.25536780000004)
Ala Thr His Arg
C19H33N9O6 (483.25536780000004)
Ala Thr Arg His
C19H33N9O6 (483.25536780000004)
His Ala Arg Thr
C19H33N9O6 (483.25536780000004)
His Ala Thr Arg
C19H33N9O6 (483.25536780000004)
His Ile Lys Ser
His Ile Ser Lys
His Lys Ile Ser
His Lys Leu Ser
His Lys Ser Ile
His Lys Ser Leu
His Lys Thr Val
His Lys Val Thr
His Leu Lys Ser
His Leu Ser Lys
His Arg Ala Thr
C19H33N9O6 (483.25536780000004)
His Arg Thr Ala
C19H33N9O6 (483.25536780000004)
His Ser Ile Lys
His Ser Lys Ile
His Ser Lys Leu
His Ser Leu Lys
His Thr Ala Arg
C19H33N9O6 (483.25536780000004)
His Thr Lys Val
His Thr Arg Ala
C19H33N9O6 (483.25536780000004)
His Thr Val Lys
His Val Lys Thr
His Val Thr Lys
Ile His Lys Ser
Ile His Ser Lys
Ile Lys His Ser
Ile Lys Ser His
Ile Pro Arg Val
C22H41N7O5 (483.31690160000005)
Ile Pro Val Arg
C22H41N7O5 (483.31690160000005)
Ile Arg Pro Val
C22H41N7O5 (483.31690160000005)
Ile Arg Val Pro
C22H41N7O5 (483.31690160000005)
Ile Ser His Lys
Ile Ser Lys His
Ile Val Pro Arg
C22H41N7O5 (483.31690160000005)
Ile Val Arg Pro
C22H41N7O5 (483.31690160000005)
Lys His Ile Ser
Lys His Leu Ser
Lys His Ser Ile
Lys His Ser Leu
Lys His Thr Val
Lys His Val Thr
Lys Ile His Ser
Lys Ile Ser His
Lys Leu His Ser
Lys Leu Ser His
Lys Ser His Ile
Lys Ser His Leu
Lys Ser Ile His
Lys Ser Leu His
Lys Thr His Val
Lys Thr Val His
Lys Val His Thr
Lys Val Thr His
Leu His Lys Ser
Leu His Ser Lys
Leu Lys His Ser
Leu Lys Ser His
Leu Pro Arg Val
C22H41N7O5 (483.31690160000005)
Leu Pro Val Arg
C22H41N7O5 (483.31690160000005)
Leu Arg Pro Val
C22H41N7O5 (483.31690160000005)
Leu Arg Val Pro
C22H41N7O5 (483.31690160000005)
Leu Ser His Lys
Leu Ser Lys His
Leu Val Pro Arg
C22H41N7O5 (483.31690160000005)
Leu Val Arg Pro
C22H41N7O5 (483.31690160000005)
Pro Ile Arg Val
C22H41N7O5 (483.31690160000005)
Pro Ile Val Arg
C22H41N7O5 (483.31690160000005)
Pro Leu Arg Val
C22H41N7O5 (483.31690160000005)
Pro Leu Val Arg
C22H41N7O5 (483.31690160000005)
Pro Arg Ile Val
C22H41N7O5 (483.31690160000005)
Pro Arg Leu Val
C22H41N7O5 (483.31690160000005)
Pro Arg Val Ile
C22H41N7O5 (483.31690160000005)
Pro Arg Val Leu
C22H41N7O5 (483.31690160000005)
Pro Val Ile Arg
C22H41N7O5 (483.31690160000005)
Pro Val Leu Arg
C22H41N7O5 (483.31690160000005)
Pro Val Arg Ile
C22H41N7O5 (483.31690160000005)
Pro Val Arg Leu
C22H41N7O5 (483.31690160000005)
Arg Ala His Thr
C19H33N9O6 (483.25536780000004)
Arg Ala Thr His
C19H33N9O6 (483.25536780000004)
Arg His Ala Thr
C19H33N9O6 (483.25536780000004)
Arg His Thr Ala
C19H33N9O6 (483.25536780000004)
Arg Ile Pro Val
C22H41N7O5 (483.31690160000005)
Arg Ile Val Pro
C22H41N7O5 (483.31690160000005)
Arg Leu Pro Val
C22H41N7O5 (483.31690160000005)
Arg Leu Val Pro
C22H41N7O5 (483.31690160000005)
Arg Pro Ile Val
C22H41N7O5 (483.31690160000005)
Arg Pro Leu Val
C22H41N7O5 (483.31690160000005)
Arg Pro Val Ile
C22H41N7O5 (483.31690160000005)
Arg Pro Val Leu
C22H41N7O5 (483.31690160000005)
Arg Thr Ala His
C19H33N9O6 (483.25536780000004)
Arg Thr His Ala
C19H33N9O6 (483.25536780000004)
Arg Val Ile Pro
C22H41N7O5 (483.31690160000005)
Arg Val Leu Pro
C22H41N7O5 (483.31690160000005)
Arg Val Pro Ile
C22H41N7O5 (483.31690160000005)
Arg Val Pro Leu
C22H41N7O5 (483.31690160000005)
Ser His Ile Lys
Ser His Lys Ile
Ser His Lys Leu
Ser His Leu Lys
Ser Ile His Lys
Ser Ile Lys His
Ser Lys His Ile
Ser Lys His Leu
Ser Lys Ile His
Ser Lys Leu His
Ser Leu His Lys
Ser Leu Lys His
Thr Ala His Arg
C19H33N9O6 (483.25536780000004)
Thr Ala Arg His
C19H33N9O6 (483.25536780000004)
Thr His Ala Arg
C19H33N9O6 (483.25536780000004)
Thr His Lys Val
Thr His Arg Ala
C19H33N9O6 (483.25536780000004)
Thr His Val Lys
Thr Lys His Val
Thr Lys Val His
Thr Arg Ala His
C19H33N9O6 (483.25536780000004)
Thr Arg His Ala
C19H33N9O6 (483.25536780000004)
Thr Val Lys His
Val His Lys Thr
Val His Thr Lys
Val Ile Pro Arg
C22H41N7O5 (483.31690160000005)
Val Ile Arg Pro
C22H41N7O5 (483.31690160000005)
Val Lys His Thr
Val Lys Thr His
Val Leu Pro Arg
C22H41N7O5 (483.31690160000005)
Val Leu Arg Pro
C22H41N7O5 (483.31690160000005)
Val Pro Ile Arg
C22H41N7O5 (483.31690160000005)
Val Pro Leu Arg
C22H41N7O5 (483.31690160000005)
Val Pro Arg Ile
C22H41N7O5 (483.31690160000005)
Val Pro Arg Leu
C22H41N7O5 (483.31690160000005)
Val Arg Ile Pro
C22H41N7O5 (483.31690160000005)
Val Arg Leu Pro
C22H41N7O5 (483.31690160000005)
Val Arg Pro Ile
C22H41N7O5 (483.31690160000005)
Val Arg Pro Leu
C22H41N7O5 (483.31690160000005)
Val Thr His Lys
Val Thr Lys His
LPS O-15:1;O
C21H42NO9P (483.25970520000004)
3-(1-Ethyl-2-methylindol-3-yl)-3-(2-ethoxy-4-diethylaminophenyl)-4-azaphthalide
2-(Hydroxyimino)-3-oxo-olean-12-en-28-oic acid
C30H45NO4 (483.33484100000004)
Glycocholic acid (hydrate)
4-[4-[4-(Diphenylmethylene)-1-piperidinyl]-1-hydroxybutyl]-α,α-dimethyl-benzeneacetic Acid
C32H37NO3 (483.27732920000005)
Otilonium
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators D005765 - Gastrointestinal Agents
Adamantane-1-carboxylic acid-5-dimethylamino-naphthalene-1-sulfonylamino-butyl-amide
N-(R-Carboxy-ethyl)-alpha-(S)-(2-phenylethyl)glycyl-L-arginine-N-phenylamide
(2S)-2,3-dihydroxypropyl (2R)-3-(hexadecanoyloxy)-2-hydroxypropyl phosphate
C22H44O9P- (483.27228040000006)
N-[2-(3,4-diethoxyphenyl)ethyl]-1-(6-morpholin-4-ylpyridazin-3-yl)piperidine-4-carboxamide
C26H37N5O4 (483.28454020000004)
2,3-dihydroxypropyl (2R)-3-(hexadecanoyloxy)-2-hydroxypropyl phosphate
C22H44O9P- (483.27228040000006)
N-[1-[1-[2-[4-(diethylamino)anilino]-2-oxoethyl]-2-benzimidazolyl]ethyl]-4-methylbenzamide
C29H33N5O2 (483.26341180000003)
N-[3-(3,5-dimethyl-1-piperidinyl)propyl]-1-(9-fluoro-[1]benzothiolo[3,2-d]pyrimidin-4-yl)-4-piperidinecarboxamide
C26H34FN5OS (483.24679660000004)
[(1S)-7-methoxy-2-(phenylmethyl)-1-(5-pyrimidinylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C29H33N5O2 (483.26341180000003)
(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
C27H37N3O5 (483.27330720000003)
(2R,3S)-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-8-(3-hydroxy-3-methylbut-1-ynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H34FN3O4 (483.25332160000005)
(2S,3S)-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-8-(3-hydroxy-3-methylbut-1-ynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H34FN3O4 (483.25332160000005)
(2S,3R)-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-8-(3-hydroxy-3-methylbut-1-ynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H34FN3O4 (483.25332160000005)
N-[(4S,7R,8S)-8-methoxy-5-[(2-methoxyphenyl)methyl]-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C27H37N3O5 (483.27330720000003)
(2R,3R)-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-8-(3-hydroxy-3-methylbut-1-ynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H34FN3O4 (483.25332160000005)
(2S,3S)-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-8-(3-hydroxy-3-methylbut-1-ynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H34FN3O4 (483.25332160000005)
(2R,3R)-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-8-(3-hydroxy-3-methylbut-1-ynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H34FN3O4 (483.25332160000005)
(2S,3R)-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-8-(3-hydroxy-3-methylbut-1-ynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H34FN3O4 (483.25332160000005)
(2R,3S)-2-[[(3-fluorophenyl)methyl-methylamino]methyl]-8-(3-hydroxy-3-methylbut-1-ynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C27H34FN3O4 (483.25332160000005)
N-[(4S,7S,8S)-8-methoxy-5-[(2-methoxyphenyl)methyl]-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C27H37N3O5 (483.27330720000003)
4-[[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzoic acid
C27H37N3O5 (483.27330720000003)
(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
C27H37N3O5 (483.27330720000003)
4-[[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzoic acid
C27H37N3O5 (483.27330720000003)
4-[[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzoic acid
C27H37N3O5 (483.27330720000003)
(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
C27H37N3O5 (483.27330720000003)
(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-8-(4-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-[(4R,7R,8R)-8-methoxy-5-[(2-methoxyphenyl)methyl]-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C27H37N3O5 (483.27330720000003)
N-[(4S,7R,8R)-8-methoxy-5-[(2-methoxyphenyl)methyl]-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C27H37N3O5 (483.27330720000003)
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(2-pyrazinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C25H33N5O5 (483.24815680000006)
N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(2-pyrazinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C25H33N5O5 (483.24815680000006)
N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(2-pyrazinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C25H33N5O5 (483.24815680000006)
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(5-pyrimidinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C26H37N5O4 (483.28454020000004)
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(2-pyrazinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C25H33N5O5 (483.24815680000006)
N-[(5R,6S,9S)-5-methoxy-8-[(4-methoxyphenyl)methyl]-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C27H37N3O5 (483.27330720000003)
N-[(5R,6R,9R)-5-methoxy-8-[(4-methoxyphenyl)methyl]-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C27H37N3O5 (483.27330720000003)
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
C25H33N5O5 (483.24815680000006)
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
C25H33N5O5 (483.24815680000006)
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
C25H33N5O5 (483.24815680000006)
2-methoxy-N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(phenylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C27H37N3O5 (483.27330720000003)
2-methoxy-N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(phenylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C27H37N3O5 (483.27330720000003)
2-methoxy-N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(phenylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C27H37N3O5 (483.27330720000003)
4-[[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzoic acid
C27H37N3O5 (483.27330720000003)
(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
C27H37N3O5 (483.27330720000003)
(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
C27H37N3O5 (483.27330720000003)
(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
C27H37N3O5 (483.27330720000003)
4-[[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzoic acid
C27H37N3O5 (483.27330720000003)
(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
C27H37N3O5 (483.27330720000003)
4-[[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl-methylamino]methyl]benzoic acid
C27H37N3O5 (483.27330720000003)
(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-8-(4-fluorophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-[(4R,7S,8R)-8-methoxy-5-[(2-methoxyphenyl)methyl]-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C27H37N3O5 (483.27330720000003)
N-[(4R,7S,8S)-8-methoxy-5-[(2-methoxyphenyl)methyl]-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C27H37N3O5 (483.27330720000003)
N-[(4S,7S,8R)-8-methoxy-5-[(2-methoxyphenyl)methyl]-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C27H37N3O5 (483.27330720000003)
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(5-pyrimidinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C26H37N5O4 (483.28454020000004)
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(5-pyrimidinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C26H37N5O4 (483.28454020000004)
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(5-pyrimidinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C26H37N5O4 (483.28454020000004)
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(5-pyrimidinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C26H37N5O4 (483.28454020000004)
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(2-pyrazinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C25H33N5O5 (483.24815680000006)
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(2-pyrazinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C25H33N5O5 (483.24815680000006)
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(5-pyrimidinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C26H37N5O4 (483.28454020000004)
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(2-pyrazinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
C25H33N5O5 (483.24815680000006)
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(5-pyrimidinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
C26H37N5O4 (483.28454020000004)
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
C25H33N5O5 (483.24815680000006)
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
C25H33N5O5 (483.24815680000006)
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
C25H33N5O5 (483.24815680000006)
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(1-oxopropyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide
C25H33N5O5 (483.24815680000006)
2-methoxy-N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(phenylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C27H37N3O5 (483.27330720000003)
2-methoxy-N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(phenylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C27H37N3O5 (483.27330720000003)
2-methoxy-N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(phenylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C27H37N3O5 (483.27330720000003)
2-methoxy-N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(phenylmethyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C27H37N3O5 (483.27330720000003)
(3R,4S,6R)-2-[[(3R,4S,5S,7R,9E,11R,12S)-12-acetyl-3,5,7,11-tetramethyl-2,8-dioxo-1-oxacyclododec-9-en-4-yl]oxy]-3-hydroxy-N,N,6-trimethyloxan-4-amine oxide
C25H41NO8 (483.28320260000004)
2-((4R)-4-((5S,9S,10S,12S,13R,14S,17R)-12-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanamido)ethane-1-sulfonic acid
C26H45NO5S (483.30182800000006)
2-Amino-3-[hydroxy-(2-hydroxy-3-pentadecanoyloxypropoxy)phosphoryl]oxypropanoic acid
C21H42NO9P (483.25970520000004)
2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxydecane-1-sulfonic acid
C26H45NO5S (483.30182800000006)
(E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxydec-4-ene-1-sulfonic acid
C26H45NO5S (483.30182800000006)
(2S)-2-amino-3-[hydroxy-[(2R)-1,1,2,3,3-pentadeuterio-2-hydroxy-3-pentadecanoyloxypropoxy]phosphoryl]oxypropanoic acid
C21H42NO9P (483.25970520000004)
2-[4-[(3R,5R,8R,9S,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoylamino]ethanesulfonic acid
C26H45NO5S (483.30182800000006)
2-[[(4R)-4-[(5S,8R,9S,10S,12R,13R,14S,17R)-12-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid
C26H45NO5S (483.30182800000006)
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1S,2R,3R,4S,6R)-4,6-diamino-3-[(2R,3S,4R,5R,6S)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol
Bekanamycin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic Bekanamycin (Kanamycin B) is an aminoglycoside antibiotic produced by Streptomyces kanamyceticus, against an array of Gram-positive and Gram-negative bacterial strain[1][2].
1-pentadecanoyl-glycero-3-phosphoserine
C21H42NO9P (483.25970520000004)
hainanate A
A steroid acid anion that is the conjugate base of hainanic acid A resulting from the deprotonation of the carboxy group; major species at pH 7.3.
1-(2-methoxy-6Z-tetradecenyl)-sn-glycero-3-phosphoserine
C21H42NO9P (483.25970520000004)
3,15,22-trihydroxy-5-methoxy-14,16-dimethyl-2-azabicyclo[18.3.1]tetracosa-1(24),2,6,8,10,16,20,22-octaen-13-yl acetate
C28H37NO6 (483.26207420000003)
5-(6-hydroxy-3,6,7-trimethyloct-1-en-3-yl)-10-isopropyl-13-(methoxymethyl)-9-methyl-3,9,12-triazatricyclo[6.6.1.0⁴,¹⁵]pentadeca-1,4,6,8(15),11-pentaen-11-ol
C29H45N3O3 (483.34607400000004)
3-methyl-2-({3-methyl-2-[1-(2-methyldecanoyl)pyrrolidine-2-carbonyloxy]butanoyl}oxy)butanoic acid
(1s,2s,3s,4r,5s,6r,8s,9r,10r,13r,14s,16s,17s,18r)-11-ethyl-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,5,8,14-tetrol
C25H41NO8 (483.28320260000004)